stocks with promising returns on investment II

52-week low/high: $42.04/$57.60

Market value: $219.4 billion

P/E ratio: 11

Yield: 2.5%

Shares in Intel, one of the world's largest semiconductor firms, sell for 11 times the average of analysts' estimates for year-ahead earnings, compared with 17 times earnings for the average tech-sector stock. Intel is little changed over the past year, despite posting record earnings in the third quarter - up 47% from the same period 12 months ago.

Although growth in PC chips is sluggish, Intel's other chips are picking up the slack. For instance, the firm's chips and associated hardware help power the fast-growing Internet of Things, and Intel's IoT sales reached record levels in the third quarter.

2. Johnson & Johnson

ViewCourtesy Johnson & Johnson

52-week low/high: $118.62/$148.75

Market value: $389.5 billion

P/E ratio: 18.3

Yield: 2.5%

Johnson & Johnson is the company behind Band-Aid brand bandages, Tylenol, Neutrogena, Listerine and more. They're not part of a high-growth market, but they're perennially marketable.

Most investors may not realize just how big of a pharmaceutical company J&J is, too. Johnson & Johnson sold $1.4 billion worth of multi-purpose intestinal drug Remicade last year, while its psoriasis therapy Stelara added $1.3 billion to the top line. The company has built-in diversity.

Drug sales are a double-edged sword. Trouble can begin once patents expire on key pharmaceuticals, such as J&J's oncology drug Zytiga. The door has been opened to a wave of generic competition that has been in the works for a while. The therapy generated $960 million worth of sales for J&J last quarter alone.

RBC Capital Markets analyst Glenn Novarro is still bullish, however. He wrote after the ruling, "While this is a negative outcome, it removes a key overhang and improves visibility on J&J's 2019 outlook ... Our analysis indicates that J&J's pharmaceutical segment can achieve mid single-digit sales growth next year."

3. Jones Lang Lasalle

 

52-week low/high: $127.02/$178.75

Market value: $6.4 billion

P/E ratio: 13

Yield: 0.6%

Jones Lang Lasalle, a global property management company, has suffered due to worries that the commercial real estate market may be weakening. Shares plunged from $172 in July to $127 in October, before rebounding some, making them attractive to value mavens.

It's a holding of Ariel Fund, founded by john rogers Ariel has held shares of its fellow Chicago-based firm since 2001.

4. JPMorgan Chase

52-week low/high: $96.85/$119.33

Market value: $369.5 billion

P/E ratio: 11

Yield: 2.9%

Higher interest rates, lower tax rates, friendlier banking regulations and a strong U.S. economy have JPMorgan Chase "firing on all cylinders," says Morningstar's Eric Compton.

Nearly half of all U.S. households do business with Chase. It's the country's biggest credit card issuer, top-ranked in global investment-banking fees and a leader in stock and bond trading. JPMorgan is "setting the pace and raising the bar," says Credit Suisse's Susan Roth Katzke.

Expect more of the same in 2019, given a robust investment-banking pipeline and decent loan growth. JPM shares yield 2.88%.

5. The New York Times Co.

View photos

52-week low/high: $19.85/$28.72

Market value: $4.5 billion

P/E ratio: 30

Yield: 0.6%

According to President Trump, the New York Times is "failing," and the industry is said to be dead. But the The New York Times Co is figuring out how to make money, mainly by raising prices for digital and paper subscriptions and by creating advertising opportunities with products such as a daily podcast. The Value Line Investment Surveynotes that earnings have fallen at an annualized rate of 20% for the past five years but are estimated to rise by an average of 42% annually for the next three to five years. The company has almost no debt.

The market value (share price times shares outstanding) is just $4.5 billion - for what's probably the best newspaper brand in the world. The only drawback is that the stock has doubled since Donald Trump's election, but shares still trade at about half of what they did in 2002.

6. Ollie's Bargain Outlet

52-week low/high: $43.05/$97.61

Market value: $5.7 billion

P/E ratio: 44

Yield: --

When e-commerce giants put brick-and-mortar retailers out of business, Ollie's Bargain Outlet stands to gain. The retailer, with 285 stores in 22 states, sells closeout and overstocked merchandise at discounted prices. Store closings present Ollie's with prospective retail space to move into and low-cost inventory to sell, says Hodges Small Cap fund manager Eric Marshall. The chain can expand its locations by 10% per year over the next few years, he says.

Ollie's is richly priced, trading at 44 times estimated earnings for the fiscal year that ends in January 2020. But analysts at Credit Suisse say the "near Amazon-proof" stock is worth it.

7. Starbucks

52-week low/high: $47.37/$68.98

Market value: $89.8 billion

P/E ratio: 26

Yield: 2.1%

Shares of Starbucks, the global coffee-shop chain, have languished for three years, and the company is facing strong domestic competition. But the market in China is perking up, and the company in May unveiled a plan to open up a new store in the country at a rate of roughly one every 15 hours through the year 2022. The company previously targeted 5,000 stores in China by 2021; now, it expects to have 6,000 stores by 2022.

Parnassus Endeavor the ground-breaking socially conscious investment fund, made a major investment in SBUX in June.

 8. Thermo Fisher

View photos

Courtesy Coolceasar via Wikipedia

52-week low/high: $181.51/$249.95

Market value: $98.0 billion

P/E ratio: 20

Yield: 0.3%

Record spending on biotech drug research is fueling demand for Thermo Fisher's lab products and services, gene-sequencing instruments, analytical tools, and diag­nostic kits.

A string of smart, well-executed acquisitions by the company has boosted sales and earnings at a 10% annualized rate since 2013. The firm's long-term debt has risen, too, but in the past, "TMO has done a good job paying down debt," says Bryn Mawr Trust's Ernie Cecilia.

Analysts expect 11% profit growth in 2019. The stock trades at 20 times estimated earnings, compared with an average multiple of 25 for its peers.

9. US Bancorp

 52-week low/high: $48.49/$58.50

Market value: $85.9 billion

P/E ratio: 12

Yield: 2.8%

situated in federal filings of Berkshire Hathaway, of what chairman Warren Buffett is buying. The latest report shows that the best investor of our time increased his stake in U.S. Bancorp, the country's largest regional bank. Buffett now owns 7.7% of the company.

Morningstar notes that, unlike money-center banks, U.S. Bancorp is "primarily funded by low-cost core deposits from the communities it serves." The bank has been lagging its peers in share-price gains but boosting its dividend aggressively.

disclaimer; this piece of information should not be used as the only source of information without an investor doing his /her own due diligence by carrying out detail investigation of a company of interest to invest in. investors are hereby encouraged to do more background checks on profiles of companies as well as their financial statements among other valuable information before investing in their company of choice. Most importantly consult a legal and investment experts. share this post with friends, longing to read your comments. see you in my next post, thanks for reading